Cargando…
A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy
OBJECTIVE: To assess the efficacy and safety of the Wenyang Huoxue method for patients with diabetic peripheral neuropathy. METHODS: A systematic literature search was performed using 7 databases: PUBMED, EMBASE, the Chinese National Knowledge Infrastructure, Wanfang, Chinese BioMedical, and the VIP...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824654/ https://www.ncbi.nlm.nih.gov/pubmed/31626140 http://dx.doi.org/10.1097/MD.0000000000017618 |
_version_ | 1783464769624211456 |
---|---|
author | Deng, Zhiyuan Wang, Manjia Fan, Yao-hua Huang, Ruilin Rao, Yawen Mai, Xurong Liu, Min |
author_facet | Deng, Zhiyuan Wang, Manjia Fan, Yao-hua Huang, Ruilin Rao, Yawen Mai, Xurong Liu, Min |
author_sort | Deng, Zhiyuan |
collection | PubMed |
description | OBJECTIVE: To assess the efficacy and safety of the Wenyang Huoxue method for patients with diabetic peripheral neuropathy. METHODS: A systematic literature search was performed using 7 databases: PUBMED, EMBASE, the Chinese National Knowledge Infrastructure, Wanfang, Chinese BioMedical, and the VIP Chinese Science and Technique Journals. The publication time was from the start of each database up to November 2018. Review Manager 5.3 software was used for assessing potential bias, data synthesis, and the subgroup analysis. Begg and Egger tests were used to assess funnel plot symmetries using Stata 14.0 software. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was used to assess the quality of evidence. RESULTS: A total of 22 trials involving 1835 participants were eligible. There were significant differences in a total effective rate between the Wenyang Huoxue method combined with Western medicine and Western medicine alone (RR = 1.33, 95% CI 1.26–1.41; P < .00001). As for the sensory conduction velocity (SCV) of the peroneal nerve, the Wenyang Huoxue method combined with Western medicine compared with Western medicine alone had a significant increase (weighted mean difference [WMD] = 5.00, 95% CI 3.42–6.57; P < .00001). Also, the Wenyang Huoxue method combined with Western medicine had significant increases in motor conduction velocity (MCV) of the peroneal nerve (WMD = 4.48, 95% CI 3.78–5.19; P < .00001), tibial nerve SCV (WMD = 3.47, 95% CI 2.66–4.28; P < .00001), tibial nerve MCV (4.87, 95% CI 3.21–6.53; P < .00001), median nerve SCV (WMD = 3.78, 95% CI 3.07–4.50; P < .00001), and median nerve MCV (WMD = 4.50, 95% CI 3.40–5.59; P < .00001). However, the effect of the Wenyang Huoxue method on fasting blood glucose, 2-h postprandial blood glucose, and glycosylated hemoglobin was not statistically significant. Egger's test results showed that there was no publication bias (P = .0008), but the trim and filling method showed steady results. An influence analysis showed that no single study affected the overall result. The GRADE quality of the evidence was low to moderate across the different outcomes. CONCLUSION: Despite of the apparently positive findings, the quality of GRADE is not high, suggesting that the Wenyang Huoxue method can improve nerve conduction velocity to a certain extent, but more rigorous literature is needed to support this evidence. |
format | Online Article Text |
id | pubmed-6824654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-68246542019-11-19 A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy Deng, Zhiyuan Wang, Manjia Fan, Yao-hua Huang, Ruilin Rao, Yawen Mai, Xurong Liu, Min Medicine (Baltimore) 3800 OBJECTIVE: To assess the efficacy and safety of the Wenyang Huoxue method for patients with diabetic peripheral neuropathy. METHODS: A systematic literature search was performed using 7 databases: PUBMED, EMBASE, the Chinese National Knowledge Infrastructure, Wanfang, Chinese BioMedical, and the VIP Chinese Science and Technique Journals. The publication time was from the start of each database up to November 2018. Review Manager 5.3 software was used for assessing potential bias, data synthesis, and the subgroup analysis. Begg and Egger tests were used to assess funnel plot symmetries using Stata 14.0 software. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was used to assess the quality of evidence. RESULTS: A total of 22 trials involving 1835 participants were eligible. There were significant differences in a total effective rate between the Wenyang Huoxue method combined with Western medicine and Western medicine alone (RR = 1.33, 95% CI 1.26–1.41; P < .00001). As for the sensory conduction velocity (SCV) of the peroneal nerve, the Wenyang Huoxue method combined with Western medicine compared with Western medicine alone had a significant increase (weighted mean difference [WMD] = 5.00, 95% CI 3.42–6.57; P < .00001). Also, the Wenyang Huoxue method combined with Western medicine had significant increases in motor conduction velocity (MCV) of the peroneal nerve (WMD = 4.48, 95% CI 3.78–5.19; P < .00001), tibial nerve SCV (WMD = 3.47, 95% CI 2.66–4.28; P < .00001), tibial nerve MCV (4.87, 95% CI 3.21–6.53; P < .00001), median nerve SCV (WMD = 3.78, 95% CI 3.07–4.50; P < .00001), and median nerve MCV (WMD = 4.50, 95% CI 3.40–5.59; P < .00001). However, the effect of the Wenyang Huoxue method on fasting blood glucose, 2-h postprandial blood glucose, and glycosylated hemoglobin was not statistically significant. Egger's test results showed that there was no publication bias (P = .0008), but the trim and filling method showed steady results. An influence analysis showed that no single study affected the overall result. The GRADE quality of the evidence was low to moderate across the different outcomes. CONCLUSION: Despite of the apparently positive findings, the quality of GRADE is not high, suggesting that the Wenyang Huoxue method can improve nerve conduction velocity to a certain extent, but more rigorous literature is needed to support this evidence. Wolters Kluwer Health 2019-10-18 /pmc/articles/PMC6824654/ /pubmed/31626140 http://dx.doi.org/10.1097/MD.0000000000017618 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 3800 Deng, Zhiyuan Wang, Manjia Fan, Yao-hua Huang, Ruilin Rao, Yawen Mai, Xurong Liu, Min A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy |
title | A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy |
title_full | A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy |
title_fullStr | A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy |
title_full_unstemmed | A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy |
title_short | A systematic review of randomized controlled trials of the Wenyang Huoxue method in treating diabetic peripheral neuropathy |
title_sort | systematic review of randomized controlled trials of the wenyang huoxue method in treating diabetic peripheral neuropathy |
topic | 3800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824654/ https://www.ncbi.nlm.nih.gov/pubmed/31626140 http://dx.doi.org/10.1097/MD.0000000000017618 |
work_keys_str_mv | AT dengzhiyuan asystematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy AT wangmanjia asystematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy AT fanyaohua asystematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy AT huangruilin asystematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy AT raoyawen asystematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy AT maixurong asystematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy AT liumin asystematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy AT dengzhiyuan systematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy AT wangmanjia systematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy AT fanyaohua systematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy AT huangruilin systematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy AT raoyawen systematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy AT maixurong systematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy AT liumin systematicreviewofrandomizedcontrolledtrialsofthewenyanghuoxuemethodintreatingdiabeticperipheralneuropathy |